TY - JOUR AU - Zulfiqar, M. I. AU - Sheikh, U. N. AU - Montgomery, E. A. PY - 2011 DA - 2011// TI - Myxoid neoplasms JO - Surg Pathol Clin VL - 4 UR - https://doi.org/10.1016/j.path.2011.08.012 DO - 10.1016/j.path.2011.08.012 ID - Zulfiqar2011 ER - TY - JOUR AU - Frampton, G. M. AU - Fitchtenholtz, A. AU - Otto, G. A. AU - Wang, K. AU - Downing, S. R. AU - He, J. PY - 2013 DA - 2013// TI - Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt.2696 DO - 10.1038/nbt.2696 ID - Frampton2013 ER - TY - STD TI - Zinner R. Pazopanib or pemetrexed and crizotinib in advanced cancer. (M.D. Anderson Cancer Center). at https://clinicaltrials.gov/ct2/show/NCT01548144. UR - https://clinicaltrials.gov/ct2/show/NCT01548144 ID - ref3 ER - TY - JOUR AU - Marino-Enriquez, A. AU - Dal, C. P. PY - 2013 DA - 2013// TI - ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages JO - Cancer Genet VL - 206 UR - https://doi.org/10.1016/j.cancergen.2013.07.001 DO - 10.1016/j.cancergen.2013.07.001 ID - Marino-Enriquez2013 ER - TY - JOUR AU - Wang, X. AU - Krishnan, C. AU - Nguyen, E. P. AU - Meyer, K. J. AU - Oliverira, J. L. AU - Yang, P. PY - 2012 DA - 2012// TI - Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor JO - Hum Pathol VL - 43 UR - https://doi.org/10.1016/j.humpath.2012.02.014 DO - 10.1016/j.humpath.2012.02.014 ID - Wang2012 ER - TY - JOUR AU - Wiesner, T. AU - He, J. AU - Yelensky, R. AU - Esteve-Puig, R. AU - Botton, T. AU - Yeh, I. PY - 2014 DA - 2014// TI - Kinase fusions are frequent in Spitz tumors and spitzoid melanomas JO - Nat Commun VL - 5 ID - Wiesner2014 ER - TY - JOUR AU - Morris, S. W. AU - Kirstein, M. N. AU - Valentine, M. B. AU - Dittmer, K. G. AU - Shapiro, D. N. AU - Saltman, D. L. PY - 1994 DA - 1994// TI - Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma JO - Science VL - 263 UR - https://doi.org/10.1126/science.8122112 DO - 10.1126/science.8122112 ID - Morris1994 ER - TY - STD TI - Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer. 2008;8. ID - ref8 ER - TY - JOUR AU - Allen, P. W. PY - 1980 DA - 1980// TI - Myxoid tumors of soft tissues JO - Pathol Annu VL - 15 ID - Allen1980 ER - TY - JOUR AU - Mackenzie, D. H. PY - 1981 DA - 1981// TI - The myxoid tumors of somatic soft tissues JO - Am J Surg Pathol VL - 5 UR - https://doi.org/10.1097/00000478-198107000-00004 DO - 10.1097/00000478-198107000-00004 ID - Mackenzie1981 ER - TY - STD TI - Graadt van Roggen JF, Hogendoorn PC, Fletcher CD. Myxoid tumours of soft tissue. Histopathology. 1999;35:291–312. ID - ref11 ER - TY - JOUR AU - Coffin, C. M. AU - Patel, A. AU - Perkins, S. AU - Elenitoba-Johnson, K. S. AU - Perlman, E. AU - Griffin, C. A. PY - 2001 DA - 2001// TI - ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor JO - Mod Pathol VL - 14 UR - https://doi.org/10.1038/modpathol.3880352 DO - 10.1038/modpathol.3880352 ID - Coffin2001 ER - TY - JOUR AU - Lovly, C. M. AU - Gupta, A. AU - Lipson, D. AU - Otto, G. AU - Brennan, T. AU - Chung, C. T. PY - 2014 DA - 2014// TI - Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-14-0377 DO - 10.1158/2159-8290.CD-14-0377 ID - Lovly2014 ER - TY - STD TI - Fraggetta F, Doglioni C, Scollo P, Pecciarini L, Ippolito M, Amico P, et al. Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass. J Clin Oncol. 2015;33. ID - ref14 ER - TY - JOUR AU - Gleason, B. C. AU - Hornick, J. L. PY - 2008 DA - 2008// TI - Inflammatory myofibroblastic tumours: where are we now? JO - J Clin Pathol VL - 61 UR - https://doi.org/10.1136/jcp.2007.049387 DO - 10.1136/jcp.2007.049387 ID - Gleason2008 ER - TY - JOUR AU - Cook, J. R. AU - Dehner, L. P. AU - Collins, M. H. AU - Ma, Z. AU - Morris, S. W. AU - Coffin, C. M. PY - 2001 DA - 2001// TI - Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study JO - Am J Surg Pathol VL - 25 UR - https://doi.org/10.1097/00000478-200111000-00003 DO - 10.1097/00000478-200111000-00003 ID - Cook2001 ER - TY - STD TI - Kushnir CL, Gerardi M, Banet N, Shih I-M, Diaz-Montes T. Extrauterine inflammatory myofibroblastic tumor: a case report. Gynecol Oncol Case Rep. 2013;6. ID - ref17 ER - TY - JOUR AU - Parra-Herran, C. AU - Quick, C. M. AU - Howitt, B. E. AU - Dal Cin, P. AU - Quade, B. J. AU - Nucci, M. R. PY - 2015 DA - 2015// TI - Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course JO - Am J Surg Pathol VL - 39 UR - https://doi.org/10.1097/PAS.0000000000000330 DO - 10.1097/PAS.0000000000000330 ID - Parra-Herran2015 ER - TY - JOUR AU - Fuehrer, N. E. AU - Keeney, G. L. AU - Ketterling, R. P. AU - Knudson, R. A. AU - Bell, D. A. PY - 2012 DA - 2012// TI - ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract JO - Arch Pathol Lab Med VL - 136 UR - https://doi.org/10.5858/arpa.2011-0341-OA DO - 10.5858/arpa.2011-0341-OA ID - Fuehrer2012 ER - TY - JOUR AU - Melloni, G. AU - Carretta, A. AU - Ciriaco, P. AU - Arrigoni, G. AU - Fieschi, S. AU - Rizzo, N. PY - 2005 DA - 2005// TI - Inflammatory pseudotumor of the lung in adults JO - Ann Thorac Surg VL - 79 UR - https://doi.org/10.1016/j.athoracsur.2004.07.077 DO - 10.1016/j.athoracsur.2004.07.077 ID - Melloni2005 ER - TY - JOUR AU - Mosse, Y. P. AU - Lim, M. S. AU - Voss, S. D. AU - Wilner, K. AU - Ruffner, K. AU - Laliberte, J. PY - 2013 DA - 2013// TI - Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children’s Oncology Group phase 1 consortium study JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70095-0 DO - 10.1016/S1470-2045(13)70095-0 ID - Mosse2013 ER - TY - JOUR AU - Kwak, E. L. AU - Bang, Y. J. AU - Camidge, D. R. AU - Shaw, A. T. AU - Solomon, B. AU - Maki, R. G. PY - 2010 DA - 2010// TI - Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1006448 DO - 10.1056/NEJMoa1006448 ID - Kwak2010 ER - TY - JOUR AU - Ou, S. H. AU - Kwak, E. L. AU - Siawak-Tapp, C. AU - Dy, J. AU - Bergethon, K. AU - Clark, J. W. PY - 2011 DA - 2011// TI - Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification JO - J Thorac Oncol VL - 6 UR - https://doi.org/10.1097/JTO.0b013e31821528d3 DO - 10.1097/JTO.0b013e31821528d3 ID - Ou2011 ER - TY - JOUR AU - Bergethon, K. AU - Shaw, A. T. AU - Ou, S. H. AU - Katayama, R. AU - Lovly, C. M. AU - McDonald, N. T. PY - 2012 DA - 2012// TI - ROS1 rearrangements define a unique molecular class of lung cancers JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.35.6345 DO - 10.1200/JCO.2011.35.6345 ID - Bergethon2012 ER - TY - JOUR AU - Butrynski, J. E. AU - D’Adamo, D. R. AU - Hornick, J. L. AU - Dal Cin, P. AU - Antonescu, C. R. AU - Jhanwar, S. C. PY - 2010 DA - 2010// TI - Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1007056 DO - 10.1056/NEJMoa1007056 ID - Butrynski2010 ER - TY - JOUR AU - Lorenzi, L. AU - Cigognetti, M. AU - Medicina, D. AU - Pellegrini, V. AU - Balzarini, P. AU - Cestari, R. PY - 2014 DA - 2014// TI - ALK-positive inflammatory myofibroblastic tumor of the abdomen with widespread microscopic multifocality JO - Int J Surg Pathol VL - 22 UR - https://doi.org/10.1177/1066896914525232 DO - 10.1177/1066896914525232 ID - Lorenzi2014 ER - TY - JOUR AU - Robert, C. AU - Karaszewska, B. AU - Schachter, J. AU - Rutkowski, P. AU - Mackiewicz, A. AU - Stroiakovski, D. PY - 2015 DA - 2015// TI - Improved overall survival in melanoma with combined dabrafenib and trametinib JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1412690 DO - 10.1056/NEJMoa1412690 ID - Robert2015 ER - TY - JOUR AU - Shaw, A. T. AU - Kim, D. W. AU - Nakagawa, K. AU - Seto, T. AU - Crino, L. AU - Ahn, M. J. PY - 2013 DA - 2013// TI - Crizotinib versus chemotherapy in advanced ALK-positive lung cancer JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1214886 DO - 10.1056/NEJMoa1214886 ID - Shaw2013 ER - TY - STD TI - Stinchcombe, T. E. Recent advances in the treatment of non-small cell and small cell lung cancer. F1000Prime Rep. 2014;6:117. ID - ref29 ER - TY - JOUR AU - Geel, R. M. AU - Beijnen, J. H. AU - Schellens, J. H. PY - 2012 DA - 2012// TI - Concise drug review: pazopanib and axitinib JO - Oncologist VL - 17 UR - https://doi.org/10.1634/theoncologist.2012-0055 DO - 10.1634/theoncologist.2012-0055 ID - Geel2012 ER -